تحميل
NASDAQHealthcareMedical - Healthcare Information Services
أحدث البيانات المتاحة
35.82 US$
+0.99 US$ · +2.84%
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
الإغلاق السابق
35.82 US$
+0.99 US$ · +2.84%
بعد ساعات التداول
35.82 US$
0.00 US$ · 0.00%
9 أكتوبر، 7:30 م ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
نطاق اليوم
السعر الحالي 35.82 US$
نطاق 52 أسبوعًا
السعر الحالي 35.82 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
51
قيمة عادلة
المشاعر
73
صعودي
المخاطر
41
مخاطر أعلى من المعتاد
الزخم
57
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
نطاق اليوم
السعر الحالي 35.82 US$
نطاق 52 أسبوعًا
السعر الحالي 35.82 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 1.18 مليار USD | 1.11 مليار USD | 1.15 مليار USD | 1.3 مليار USD | 1.13 مليار USD |
| تكلفة البضاعة المباعة | 676.8 مليون USD | 641.24 مليون USD | 647.18 مليون USD | 706.96 مليون USD | 577.37 مليون USD |
| الربح الإجمالي | 508.04 مليون USD | 471 مليون USD | 499.93 مليون USD | 588.99 مليون USD | 554.65 مليون USD |
| البحث والتطوير | 87.74 مليون USD | 90.41 مليون USD | 93.29 مليون USD | 104.97 مليون USD | 75.72 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 408.64 مليون USD | 380.25 مليون USD | 425.97 مليون USD | 486.34 مليون USD | 389.43 مليون USD |
| نفقات التشغيل | 496.38 مليون USD | 470.67 مليون USD | 519.26 مليون USD | 591.31 مليون USD | 465.15 مليون USD |
| دخل الفوائد | 11.9 مليون USD | 24.9 مليون USD | 14.76 مليون USD | — | — |
| مصاريف الفوائد | 3.91 مليون USD | 4.53 مليون USD | — | 130 ألف USD | 22.39 مليون USD |
| الاستهلاك والإطفاء | 86.63 مليون USD | 89.76 مليون USD | 95.56 مليون USD | 99.17 مليون USD | 84.93 مليون USD |
| الدخل التشغيلي | 11.67 مليون USD | 337 ألف USD | −19.33 مليون USD | −2.32 مليون USD | 89.51 مليون USD |
| صافي الدخل | 2.05 مليون USD | 12.53 مليون USD | −20.37 مليون USD | 5.65 مليون USD | 77.85 مليون USD |
تم تحديث حقائق الشركة 10 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI48.12 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
iShares Russell 2000 ETFIWM41.85 مليون0.05%78.27 مليار USD0.19%278.94 US$+0.49%
Vanguard Morningstar Small-Cap ETFVB34.92 مليون0.02%185.3 مليار USD0.03%289.48 US$+0.64%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV30.39 مليون0.11%26.81 مليار USD0.33%37.95 US$-0.39%
Vanguard Morningstar Small-Cap Value ETFVBR22.2 مليون0.03%68.2 مليار USD0.05%234.43 US$+0.22%
Vanguard Extended Market ETFVXF18.61 مليون0.02%95.4 مليار USD0.05%235 US$+0.80%
Dimensional - US Targeted Value ETFDFAT17.08 مليون0.06%30.12 مليار USD0.33%67.27 US$-0.43%
iShares Russell 2000 Value ETFIWN14.81 مليون0.11%13.85 مليار USD0.24%210.87 US$-0.04%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATiShares Russell 2000 Value ETFIWNالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
